Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-048897
Filing Date
2011-09-23
Accepted
2011-09-23 17:02:57
Documents
2
Period of Report
2011-09-21

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c22693_4x1.html 4  
1 MAIN DOCUMENT DESCRIPTION c22693_4x1.xml 4 5478
2 ADDITIONAL EXHIBITS c22693_99.htm EX-99 25563
  Complete submission text file 0001209191-11-048897.txt   33152
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Issuer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, SECOND FLOOR MENLO PARK CA 94025
Business Address
Kjellson Nina S (Reporting) CIK: 0001381980 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51967 | Film No.: 111105699

Mailing Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025
Business Address 2710 SAND HILL ROAD SECOND FLOOR MENLO PARK CA 94025 650-854-8585
InterWest Management Partners IX, LLC (Reporting) CIK: 0001398927 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-51967 | Film No.: 111105700